Sun Pharma's Q2 net profit fell 36% due to one-time charges. Revenue rose 12%, with India formulation sales up 17.3%. Charges included a US antitrust settlement and Organon acquisition costs.
https://www.business-standard.com/companies/quarterly-results/sun-pharma-q2-net-profit-falls-36-on-one-time-charges-revenue-rises-12-126103001717_1.html
Image:
#pharma #revenue #charges #profit
https://www.business-standard.com/companies/quarterly-results/sun-pharma-q2-net-profit-falls-36-on-one-time-charges-revenue-rises-12-126103001717_1.html
Image:
#pharma #revenue #charges #profit
Views: 8
Categories: News & Updates [c3], Projects & Resources [c5]